|
Age (years)
|
43.21 ± 12.99
|
|
Sex (female/male), n (%)
|
47/60 (43.9/56.1)
|
|
BMI (kg/m2)
|
24.92 ± 5.17
|
|
PTDM, n (%)
|
33 (32.4)
|
|
HTN, n (%)
|
26 (26)
|
|
HLP, n (%)
|
27 (26.5)
|
|
Rejection, n (%)
|
31 (35.2)
|
|
Etiology of liver disease (n, %)
|
|
HBV
|
19 (17.7)
|
|
HCV
|
4 (3.7)
|
|
NASH
|
14 (13)
|
|
AIH
|
11 (10.2)
|
|
PSC
|
21 (19.6)
|
|
Cryptogenic
|
15 (14)
|
|
Others
|
23 (21.4)
|
|
AST (IU/L)
|
19 (9–164)
|
|
ALT (IU/L)
|
22.5 (8–226)
|
|
Alk.Phos (IU/L)
|
200 (44–800)
|
|
Steatosis in TE (n, %)
|
37 (34.6)
|
|
Mean CAP (dB/m)
|
207.76 ± 56.84
|
|
TM6SF2 rs58542926 genotype (n, %)
|
|
CC
|
77 (71.9)
|
|
CT
|
28 (26.1)
|
|
TT
|
2 (1.8)
|
|
PCSK9 rs505151 genotype (n, %)
|
|
AA
|
54 (50.4)
|
|
AG
|
50 (46.7)
|
|
GG
|
3 (2.8)
|
|
PCSK7 rs2277287 genotype (n, %)
|
|
CC
|
26 (24.2)
|
|
CT
|
44 (41.1)
|
|
TT
|
37 (34.5)
|
